Denali Therapeutics Inc (DNLI) Annual Income Statement (USD)
DNLI Quarterly Financials (USD)
Frequently Asked Questions About Denali Therapeutics Inc (DNLI) Stock
Denali Therapeutics Inc's (DNLI) last reported annual revenue was USD 0.00.
Denali Therapeutics Inc's (DNLI) annual revenue growth rate based on the revenue reported in the past 5 years is : N/A
Denali Therapeutics Inc's(DNLI) is not profitable as of its last reported annual financials.
The net profit margin for Denali Therapeutics Inc's(DNLI) from its laster reported year is N/A
The return on equity (ROE) for Denali Therapeutics Inc's(DNLI) from its last reported annual financials is : -37.40%
The return on assets (ROA) for Denali Therapeutics Inc's(DNLI) from its last reported annual financials is : -24.82%
The return on invested capital (ROIC) for Denali Therapeutics Inc's(DNLI) from its last reported annual financials is : -43.11%
The Debt to Equity ratio for Denali Therapeutics Inc's(DNLI) from its last reported annual financials is : 0.00%
The dividend yield for Denali Therapeutics Inc's(DNLI) from its laster reported year is 0.00%
Denali Therapeutics Inc's(DNLI) has negative cash flow as of its last reported annual financials.
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median dividend returns
The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.
Poor risk adjusted returns
This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for DNLI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
